Protective Effects of Gynostemma pentaphyllum (var. Ginpent) against Lipopolysaccharide-Induced Inflammation and Motor Alteration in Mice.
Andrea MastinuSara Anna BoniniMarika PremoliGiuseppina MaccarinelliEileen Mac SweeneyLeilei ZhangChristophe El-NakhelMaurizio MemoPublished in: Molecules (Basel, Switzerland) (2021)
Gynostemma pentaphyllum (var. Ginpent) (GP) is a variety of Cucurbit with anti-inflammatory and antioxidant effects in patients. In this manuscript, the main components present in the dry extract of GP have been identified using Ultra High Performance Liquid Chromatography quadrupole-time-of-flight mass spectrometry (UHPLC/Q-TOF-MS). In addition, the anti-inflammatory action of GP was evaluated in animal models with acute peripheral inflammation and motor alteration induced by lipopolysaccharide. The results showed that GP dry extract is rich in secondary metabolites with potential antioxidant and anti-inflammatory properties. We found that the treatment with GP induced a recovery of motor function measured with the rotarod test and pole test, and a reduction in inflammatory cytokines such as interleukin-1β and interleukin-6 measured with the ELISA test. The data collected in this study on the effects of GP in in vivo models may help integrate the therapeutic strategies of inflammatory-based disorders.
Keyphrases
- anti inflammatory
- oxidative stress
- lipopolysaccharide induced
- tandem mass spectrometry
- ultra high performance liquid chromatography
- inflammatory response
- simultaneous determination
- end stage renal disease
- ms ms
- diabetic rats
- mass spectrometry
- liquid chromatography
- high resolution mass spectrometry
- newly diagnosed
- chronic kidney disease
- ejection fraction
- drug induced
- toll like receptor
- type diabetes
- peritoneal dialysis
- electronic health record
- high performance liquid chromatography
- solid phase extraction
- high glucose
- gas chromatography
- high resolution
- patient reported outcomes
- immune response
- deep learning
- high fat diet induced
- combination therapy
- patient reported